GlassScriptPhysician profile
Nakia Sarad
NPI 1124681762
$1,277.97
in general payments reported to CMS, 2019-2025
9 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $235 · 2024: $835 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $898 · Education: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.03 |
| Education | $379.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $620.30 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $195.20 | 2023-2025 | Endurant Iis, Sonicision |
| Endologix LLC | $179.14 | 2024 | Endocross Device, Torus Stent Graft System |
| Cook Medical LLC | $99.29 | 2024 | Zilver Vena |
| Davol INC. | $52.04 | 2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $46.62 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbott Laboratories | $35.44 | 2023 | Jeti Peripheral Catheter |
| Kci USA, INC. | $27.08 | 2023 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Baxter Healthcare | $22.86 | 2025 | Seprafilm, Coseal, Perclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nakia Sarad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.